Paul Tudor Jones’s Abiomed Inc ABMD Stock Holding History

Paul Tudor Jones’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,600	Closed	-$395K	–	3005
2022 Q3	$395K	Buy	1,600 +400	+33%	+$108K	0.01%	1575
2022 Q2	$297K	Buy	+1,200	New	+$324K	0.01%	1572
2021 Q3	–	Sell	-1,100	Closed	-$343K	–	2932
2021 Q2	$343K	Buy	+1,100	New	+$337K	0.01%	1302

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Paul Tudor Jones's ABMD Position: Q4 2022 in Review

Paul Tudor Jones sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 7,295 shares — an estimated $1.79M sold.

Paul Tudor Jones first reported a position in ABMD in Q3 2013 and held it in 17 quarters. The position peaked at $5.84M in Q4 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Paul Tudor Jones reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Paul Tudor Jones sold 7,295 Abiomed Inc shares in Q4 2022, an estimated $1.79M.
Paul Tudor Jones first reported a position in Abiomed Inc in Q3 2013 and held it in 17 quarters.
Paul Tudor Jones's Abiomed Inc position peaked at $5.84M in Q4 2019.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.